AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Travere Therapeutics Appoints Bradley L. Campbell as Chief Executive Officer
PUBLIC · TVTXSep 21, 2026•about 4 hours ago
Position
Chief Executive Officer
Company
Travere Therapeutics
Bradley L. Campbell
BiotechnologyHealth CareTherapeutics
Description
Travere Therapeutics announced that Eric Dube, Ph.D., will step down as president and chief executive officer to focus on his health and family. The company has appointed Bradley L. Campbell to succeed him as president and chief executive officer.
Company Information
Company
Travere Therapeutics
About
Travere Therapeutics, Inc. is a biotechnology company focused on developing and commercializing innovative therapies for people living with rare diseases. It specializes in addressing unmet medical needs associated with kidney diseases. The company aims to improve treatment outcomes for patients through scientific advancements and breakthroughs in drug development.
Fundz sees it the moment Travere Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
